ROBERT J MORE
CIK 1207792 · last filed 2026-06-01
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$108.64M
Companies
9
Total Filings
51
Lifetime Open-Market Net
-$6.82M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TYRA | Director | 3,823,425 | $26.99 | $103.19M | -$2.75M | 8 | 2026-06-01 |
| VIR | Director | 558,573 | $8.61 | $4.81M | -$3.44M | 20 | 2026-05-28 |
| Allakos Inc. (ALLK) Delisted | 2,101,401 | $0.33 | $691.6K | -$4.54M | 2 | 2021-03-05 | |
| Sienna Biopharmaceuticals, Inc. (SNNA) Delisted | Director | 255,942 | — | — | -$209.4K | 5 | 2019-06-03 |
| GKOS | Director | 5,000 | $126.81 | $634.0K | $90.0K | 1 | 2015-06-30 |
| Volcano Corp (VOLC) Delisted | 10%+ Owner | 2,663,166 | — | — | -$1.69M | 10 | 2008-07-18 |
| CADENCE PHARMACEUTICALS INC (CADX) Delisted | 10%+ Owner | 90,369 | — | — | $0 | 1 | 2008-02-22 |
| Orexigen Therapeutics, Inc. (OREX) Delisted | 10%+ Owner | 18,569 | — | — | $6.00M | 2 | 2007-11-29 |
| Paratek Pharmaceuticals, Inc. (NOVC) Delisted | 10%+ Owner | 73,575 | — | — | -$275.9K | 2 | 2007-06-06 |
Recent Filings · Page 4 of 6
51 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-06-03 | Sienna Biopharmaceuticals, Inc. (SNNA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-02-26 | Sienna Biopharmaceuticals, Inc. (SNNA) Delisted | Buy (P) | +100,000 | $250.0K | EDGAR |
| 2018-06-04 | Sienna Biopharmaceuticals, Inc. (SNNA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-03-29 | Sienna Biopharmaceuticals, Inc. (SNNA) Delisted | Sell (S) | −24,429 | -$459.4K | EDGAR |
| 2017-08-01 | Sienna Biopharmaceuticals, Inc. (SNNA) Delisted | Conv (C) | +169,178 | $0 | EDGAR |
| 2015-06-30 | GKOS | Buy (P) | +5,000 | $90.0K | EDGAR |
| 2008-07-18 | Volcano Corp (VOLC) Delisted | Mixed | −678,366 | -$226.8K | EDGAR |
| 2008-06-09 | Volcano Corp (VOLC) Delisted | Other (J) | +18,318 | $0 | EDGAR |
| 2008-04-10 | Volcano Corp (VOLC) Delisted | Mixed | −589,883 | -$176.7K | EDGAR |
| 2008-02-22 | CADENCE PHARMACEUTICALS INC (CADX) Delisted | Grant (A) | +2,808,988 | $15.00M | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.